Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

282 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
HER2 dendritic cell vaccines.
Morse MA, Clay TM, Colling K, Hobeika A, Grabstein K, Cheever MA, Lyerly HK. Morse MA, et al. Among authors: lyerly hk. Clin Breast Cancer. 2003 Feb;3 Suppl 4:S164-72. doi: 10.3816/cbc.2003.s.007. Clin Breast Cancer. 2003. PMID: 12620155 Clinical Trial.
Immune monitoring.
Mosca PJ, Clay TM, Morse MA, Lyerly HK. Mosca PJ, et al. Among authors: lyerly hk. Cancer Treat Res. 2005;123:369-88. doi: 10.1007/0-387-27545-2_16. Cancer Treat Res. 2005. PMID: 16211879 Review.
Gene therapy for lung cancer.
Toloza EM, Morse MA, Lyerly HK. Toloza EM, et al. Among authors: lyerly hk. J Cell Biochem. 2006 Sep 1;99(1):1-22. doi: 10.1002/jcb.20851. J Cell Biochem. 2006. PMID: 16767697 Review.
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity.
Hartman ZC, Wei J, Osada T, Glass O, Lei G, Yang XY, Peplinski S, Kim DW, Xia W, Spector N, Marks J, Barry W, Hobeika A, Devi G, Amalfitano A, Morse MA, Lyerly HK, Clay TM. Hartman ZC, et al. Among authors: lyerly hk. Clin Cancer Res. 2010 Mar 1;16(5):1466-77. doi: 10.1158/1078-0432.CCR-09-2549. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179231 Free PMC article.
282 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page